Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Shavin

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cutis|March 13, 2003
Implications of the BEST studyJoel Shavin, Jonathan Weiss
Cutis|March 13, 2003
Overall results of the BEST study following treatment of patients with mild to moderate acneJonathan Weiss, Joel Shavin, Matthew W Davis
Clinical Therapeutics|December 5, 2002
Preliminary results of a nonrandomized, multicenter, open-label study of patient satisfaction after treatment with combination benzoyl peroxide/clindamycin topical gel for mild to moderate acneJonathan W Weiss, Joel Shavin, Matthew Davis
Cutis|March 13, 2003
Improving patient satisfaction and acne severity in patients with mild to moderate acne: the BEST studyJonathan Weiss, Joel Shavin, Matthew W Davis
Cutis|August 2, 2003
Efficacy and safety of a new triple-combination agent for the treatment of facial melasmaSusan C Taylor, Helen Torok, Terry Jones, et al.
American Journal of Clinical Dermatology|August 3, 2005
Long-term efficacy and safety of tretinoin emollient cream 0.05% in the treatment of photodamaged facial skin: a two-year, randomized, placebo-controlled trialSewon Kang, Wilma Bergfeld, Alice B Gottlieb, et al.
Journal of the American Academy of Dermatology|February 28, 2004
A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgarisJames Leyden, Wilma Bergfeld, Lynn Drake, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cutis|March 13, 2003
Implications of the BEST studyJoel Shavin, Jonathan Weiss
Cutis|March 13, 2003
Overall results of the BEST study following treatment of patients with mild to moderate acneJonathan Weiss, Joel Shavin, Matthew W Davis
Clinical Therapeutics|December 5, 2002
Preliminary results of a nonrandomized, multicenter, open-label study of patient satisfaction after treatment with combination benzoyl peroxide/clindamycin topical gel for mild to moderate acneJonathan W Weiss, Joel Shavin, Matthew Davis
Cutis|March 13, 2003
Improving patient satisfaction and acne severity in patients with mild to moderate acne: the BEST studyJonathan Weiss, Joel Shavin, Matthew W Davis
Cutis|August 2, 2003
Efficacy and safety of a new triple-combination agent for the treatment of facial melasmaSusan C Taylor, Helen Torok, Terry Jones, et al.
American Journal of Clinical Dermatology|August 3, 2005
Long-term efficacy and safety of tretinoin emollient cream 0.05% in the treatment of photodamaged facial skin: a two-year, randomized, placebo-controlled trialSewon Kang, Wilma Bergfeld, Alice B Gottlieb, et al.
Journal of the American Academy of Dermatology|February 28, 2004
A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgarisJames Leyden, Wilma Bergfeld, Lynn Drake, et al.
Pageof 1